Articles

The deal is expected to help boost supply of Wegovy.

Novo Nordisk’s Parent Company Purchases Catalent for $16.5 Billion

Pharma Commerce travels to Orlando for a pulse-check on this fast-evolving landscape in patient care.  

Access Insights and Information Abound

And the need to boost awareness of this critical healthcare resource.

A Look at the Medicare 'Extra Help' Program

An analysis of the two main new models for pharmacy—unique direct—to-consumer for brands and cash pay for generics—and what members of industry think about them.

Who Moved My Prescription? Part II

An analysis conducted by RAND Corporation determines that majority of new Rx medications are first sold in the United States before making their debut in other countries. 

A Comparison of Prescription Drug Availability 

New reservation program for Beyfortus (nirsevimab-alip) seeks to improve access to the monoclonal antibody that is FDA-approved to protect against respiratory syncytial virus-associated lower respiratory tract disease.

Sanofi, AstraZeneca Launch Program to Mitigate Future RSV Vaccine Shortages

A dive into this market reveals that the latest numbers yield promising results—a global value of a worldwide $1.6 trillion—but it will continue to be attributed to past, present, and future healthcare spending. 

The Path for Prescription Drug Sales 

Allarity reached an agreement with Novartis in 2018 to license dovitinib, a small molecule multi-tyrosine kinase inhibitor under evaluation for the treatment of renal cell carcinoma.

Allarity Loses Rights to Cancer Drug Dovitinib After Missing Payments to Novartis

Treatment with the novel engineered T-cell receptor produced an overall response rate of about 39% in patients with heavily pretreated synovial sarcoma.

Afamitresgene Autoleucel Granted FDA Priority Review for Advanced Synovial Sarcoma

Leading experts in the sector explore the value of third-party logistics providers when it comes to fortifying pharmaceutical supply chains. 

News